This is a prospective registry study to surveil early liver injuries caused by Runzao Zhiyang Capsule (RZZY Capsule) through a non-intervention observational way. And attempt to establish a predictive model to screen susceptibilities to RZZY Capsule.
The primary objectives of this study include: (i) The detection of patients with serum liver biochemistry abnormalities less than 8 weeks after intake of RZZY Capsule; (ii) The record of overall individuals with demographics, underlying diseases, physical status, medication information, clinical laboratory index, and so on; (iii) The specimen collection of surveiled individuals. (iv) The attempt to establish a predictive model to screen susceptibilities to RZZY Capsule.
Study Type
OBSERVATIONAL
Enrollment
1,000
302 Military Hospital
Beijing, Beijing Municipality, China
The detection of patients with serum liver biochemistry abnormalities within 8 weeks after intake of RZZY Capsule.
The detection of patients with serum liver biochemistry abnormalities within 8 weeks after intake of RZZY Capsule.
Time frame: participants will be followed duration intake of RZZY Capsule, an expected average within 8 weeks
Clinical features of early liver injuries caused by RZZY Capsule assessed by serum parameters of liver function.
Clinical features of early liver injuries caused by RZZY Capsule assessed by serum parameters of liver function.
Time frame: participants will be followed duration intake of RZZY Capsule, an expected average of 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.